If you're experiencing symptoms of trichomoniasis, see your doctor or healthcare provider to receive the appropriate treatment.
To diagnose trichomoniasis, your doctor will ask you about your medical history, sexual behavior, and symptoms, and will perform a physical examination and lab tests.1
The infection can be difficult to detect in men. In women, however, your doctor can perform a pelvic exam to check for small red sores or inflammation on the vaginal wall or cervix.2 He or she will also take a sample of your vaginal fluid to examine under a microscope and send to a lab for further testing.
As with BV infections, it is important to accurately diagnose TV infections to avoid the risk of other health problems that can develop if the disease is left untreated. These consequences include infertility, pre-term labor, and pelvic inflammatory disease.2,3
If you are diagnosed with trichomoniasis, your doctor may prescribe Tindamax® to cure the infection.
Important Safety Information
WARNING: POTENTIAL RISK FOR CARCINOGENICITY
Carcinogenicity has been seen in mice and rats treated chronically with metronidazole, another nitroimidazole agent. Although such data have not been reported for tinidazole, the two drugs are structurally related and have similar biologic effects. Its use should be reserved for the conditions described in INDICATIONS AND USAGE.
Contraindications
- Prior history of hypersensitivity to tinidazole or other nitroimidazole derivatives
- First trimester of pregnancy
- Nursing mothers, unless breast-feeding is interrupted during tinidazole therapy and for 3 days following the last dose
Warnings and Precautions
- Seizures and neuropathy have been reported. Discontinue Tindamax if abnormal neurologic signs develop
- Vaginal candidiasis may develop with Tindamax and require treatment with an antifungal agent
- Use Tindamax with caution in patients with blood dyscrasias. Tindamax may produce transient leukopenia and neutropenia
Adverse Reactions
Most common adverse reactions for a single 2 g dose of tinidazole (incidence >1%) are metallic/bitter taste, nausea, weakness/fatigue/malaise, dyspepsia/cramps/epigastric discomfort, vomiting, anorexia, headache, dizziness and constipation. To report SUSPECTED ADVERSE REACTIONS, contact Mission Pharmacal Company at 1-800-298-1087 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
This material is intended to provide basic information. Patients should discuss all medical advice, diagnosis, and treatment with their healthcare provider.
Please see full Prescribing Information
- Ferris DG, Hendrich J, Payne PM, Getts A, Rassekh R, Mathis D, Litaker MS. Office laboratory diagnosis of vaginitis. Clinician-performed tests compared with a rapid nucleic acid hybridization test. J Fam Pract. 1995 Dec;41(6):575-81.
- Trichomoniasis CDC Fact Sheet [Internet]. CDC; 2007 Dec [accessed 2008 Jul 18]. Available from: http://www.cdc.gov/STD/Trichomonas/Trichomoniasis-Fact-Sheet.pdf
- Sweet RL. Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol. 2000;8(3-4):184-90.
- Nanda N, Michel RG, Kurdgelashvili G, Wendel KA. Trichomoniasis and its treatment. Expert Rev Anti Infect Ther. 2006 Feb;4(1):125-35.
Websites
For Health Professionals
Only Tindamax® is approved to treat both bacterial vaginosis and trichomoniasis (TV).
Clinical Insight
Oral vs vaginal cream therapy: Patient preference for oral dosing is demonstrated to be 84%. More»
Beyond BV
Tindamax® may be prescribed for other infections including:
The Mission Pharmacal family of products
Learn more about innovative therapies including...
CitraNatal®Calcium citrate with vital nutrients for mother and baby » Ferralet® 90The iron therapy with biocomplementary absorption » Urocit®-KKidney stone therapy with wax-matrix delivery for slow, sustained release »
